AstraZenecas

© Reuters. FILE PHOTO: A company logo is seen at the AstraZeneca site in Macclesfield, Britain, May 11, 2021. REUTERS/Phil Noble (Corrects typo in headline to read "prostate", not "prostrate") (Reuters) -A panel of U.S. Food and Drug…

AstraZeneca's (AZN) TAGRISSO demonstrated strong OS benefit in ADAURA Phase III trial for adjuvant treatment of patients with early-stage EGFR-mutated lung cancer Positive high-level results from the ADAURA Phase III trial showed…

A separate Phase IV trial reported in a preprint with The Lancet showed that a third dose of Vaxzevria substantially increased antibody levels following a primary vaccine series with CoronaVac (Sinovac Biotech). AstraZeneca on Thursday…

LONDON— AstraZeneca AZN -0.76% PLC’s Covid-19 vaccine isn’t authorized in the U.S., and governments in Canada, Australia and across Western Europe have shunned it after production problems…

When Pascal Soriot unveiled AstraZeneca’s new vaccine strategy he could scarcely hide his exasperation. After thrusting his company into the frontline of the battle against Covid by developing a low-cost jab, the chief executive appeared…

London, November 19 A single shot of an antibody treatment against Covid-19 developed by UK drug major AstraZeneca is 83 per cent capable to reduce the risk of the infectious disease…

AstraZeneca says its cocktail of antibodies, AZD7442, has given results deemed positive against Covid-19 during phase III clinical trials.Gerard Bottino | SOPA Images | LightRocket | Getty ImagesAstraZeneca's antibody treatment has been…

It means the body can continue making these vital cells long after the antibodies have waned, as possibly for the rest of your life, it said. Scientists from Oxford, the UK, and Switzerland, writing in the journal Nature, said that…

New Delhi, May 26  In the first of its kind study since the launch of the AstraZeneca's Covishield and Bharat Biotech's Covaxin in the country, the Indian Council of Medical Research (ICMR)…

The Covid-19 vaccine developed by AstraZeneca and the University of Oxford brought in $275 million in sales from about 68 million doses delivered in the first three months of this year, AstraZeneca reported on Friday.AstraZeneca disclosed…